COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 160 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,001 | +4.0% | 358 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $7,693 | -10.4% | 358 | 0.0% | 0.00% | -20.0% |
| Q1 2023 | $8,588 | +35.6% | 358 | +31.1% | 0.01% | +25.0% |
| Q4 2022 | $6,334 | +26.7% | 273 | -20.4% | 0.00% | +33.3% |
| Q3 2022 | $5,000 | -16.7% | 343 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $6,000 | +50.0% | 343 | +61.8% | 0.00% | +100.0% |
| Q4 2021 | $4,000 | 0.0% | 212 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $4,000 | -20.0% | 212 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $5,000 | 0.0% | 212 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $5,000 | +25.0% | 212 | -10.9% | 0.00% | 0.0% |
| Q4 2020 | $4,000 | 0.0% | 238 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $4,000 | -20.0% | 238 | -42.1% | 0.00% | +33.3% |
| Q3 2019 | $5,000 | -16.7% | 411 | -8.3% | 0.00% | -25.0% |
| Q2 2019 | $6,000 | -14.3% | 448 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $7,000 | 0.0% | 448 | -3.9% | 0.01% | +66.7% |
| Q3 2018 | $7,000 | – | 466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,887,332 | $34,840,000 | 5.65% |
| SECTORAL ASSET MANAGEMENT INC | 1,426,862 | $26,340,000 | 3.29% |
| Eventide Asset Management | 2,207,610 | $40,752,000 | 2.12% |
| Rock Springs Capital Management LP | 1,885,729 | $34,811,000 | 1.58% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 460,000 | $8,492,000 | 1.11% |
| Cormorant Asset Management, LP | 300,000 | $5,538,000 | 0.58% |
| HIGHLAND CAPITAL MANAGEMENT LP | 579,234 | $10,693,000 | 0.49% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,389,863 | $25,657,000 | 0.39% |
| NBW CAPITAL LLC | 69,050 | $1,275,000 | 0.34% |
| NEXT CENTURY GROWTH INVESTORS LLC | 144,972 | $2,676,000 | 0.33% |